Circulating levels of cytokines (IL-6 and IL-1β) in patients with intermittent claudication, at rest, after maximal exercise treadmill test and during restore phase. Could they be progression markers of the disease?

International Angiology

Volumn 26, Issue 3, 2007, Pages 245-252

  Andreozzi, Giuseppe Maria ^a   Martini, R ^a   Cordova, R ^a   D'Eri, A ^a   Salmistraro, G ^a   Mussap, M ^a   Plebani, M ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Acute phase proteins; C reactive protein; Cytokines; Exercise test; Inflammation; Intermittent claudication; Peripheral arterial disease

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EXERCISE INTENSITY; EXERCISE RECOVERY; HUMAN; INFLAMMATION; INTERMITTENT CLAUDICATION; LEG PAIN; MALE; PAIN ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TREADMILL EXERCISE;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CHEMILUMINESCENT MEASUREMENTS; EXERCISE; EXERCISE TEST; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PROGNOSIS; RECOVERY OF FUNCTION; REST; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 34848904182     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hickman P, McCollum PT, Belch JJ. Neutrophils may contribute to the morbidity and mortality of claudicants. Br J Surg 1994;81:790-8
2. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Serum vitamin C concentration is low in PAD ad is associated with inflammation and severity of atherosclerosis. Circulation 2001;103:1863-8.
3. Signorelli SS, Mazzarino MC, Di Pino L, Malaponte G, Porto C, Pennisi G et al. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med 2003;8:15-9.
4. Brevetti G, Martone VD, de Cristofaro T, Corrado S, Silvestro A, Di Donato AM et al. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 2001;85:63-6.
5. Corrado E, Muratori I, Tantillo R, Contorno F, Coppola G, Strano A et al. Relationship between endothelial dysfunction, intima media thickness and cardiovascular risk factors in asymptomatic subjects. Int Angiol 2005;24: 52-8.
6. Edwards AT, Blann AD, Suarez-Mendez VJ, Lardi AM, McCollum CN. Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg 1994;81:1738-41.
7. Hickman P, Harrison DK, Hill A, McLaren M, Tamei H, McCollum PT et al. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol 1994;361:565-70.
8. Lombardo A, Biasucci LM, Lanza GA, Coli S, Silvestri P, Cianflone D et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004;109:3158-63.
9. Biasucci LM, Bitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-7.
10. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of inhospital coronary events. Circulation 1999;99:2079-84.
11. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998;98:2370-6.
12. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev 2000;8:31-9.
13. Liuba P, Karnani P, Pesonen E, Paakkari I, Forslid A, Johansson L et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice. Circulation 2000;102:1039-44.
14. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
15. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque. Part I: Evolving concepts. J Am Coll Cardiol 2005;46:937-54.
16. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767.
17. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol 2005;96: 1374-8.
18. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992;35:982-4.
19. Fontaine R, Kieny R, Gangloff JM, Cuny A, Sudler A, Gonzales I et al. Long-term restorative arterial surgery in obstructive diseases of the arteries. J Cardiov Surg 1964 5:463-472
20. Rutherford RB, Baker LD, Ernst C, Johnston KW, Porter JM, Ahn S et al: Recommended standards for reports dealing with lower limb extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
21. Andreozzi GM. Flow dynamics and pathophysiological mechanisms of diseases of lower limbs arteries. In: Salmasi M, Strano A, editors. Angiology in practice. London: Kluwer Ed; 1996.p.251-70.
22. Andreozzi GM, Leone A, Laudani R, Deinite G, Martini R. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training. Int Angiology 2007;26:12-7.
23. McDermott MM, Guralnik JM, Greenland P, Green D, Liu K, Ridker PM et al. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2004;52:1888-94.
24. Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 2003;38:374-9.
25. Jelnes R, Gaardsting O, Hougaard Jensen K, Backgaard N, Tomnesen KH, Schroeder T et al. Fate in intermittent claudication: outcome and risk factors. Br Med J 1986;293:1137-40.
26. Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dumba J, Housley E et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25:1172-81.
27. Coran AG, Warren R. Arteriographic changes in femoropopliteal arteriosclerosis obliterans. A five years follow-up study. N Engl J Med 1966;274:643-7
28. Brevetti G, Martone VD, Perna S, Cacciatore F, Corrado S, Di Donato A et al. Intermittent claudication and risk of cardiovascular events. Angiology 1998;49:843-8.
29. Andreozzi GM, Martini R. The fate of the claudicant limb. Eur Heart J Suppl 2002;4:B41-B45.
30. Andreozzi GM, Arosio E, Martini R, Verlato F, Visonà A. Consensus on Intermittent Claudication. Abano Terme (PD), Italy, 7th May 2005. Milano: Adis Wolters Kluwer Health; 2005.
31. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rurnley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
32. Tall AR. C-reactive protein reassessed. N Engl J Med 2004;350:1450-2.